Diffuse neonatal haemangiomatosis

Journal of Paediatrics and Child Health

Volumn 36, Issue 3, 2000, Pages 286-289

  Ho, V W G ^a   Krol, A ^a   Bhargava, R ^a   Osiovich, H ^a,b  

^a UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Diffuse neonatal haemangiomatosis; Haemangioma; Multiple miliary haemangiomatosis

Indexed keywords

ALPHA2A INTERFERON; CORTICOSTEROID;

ARTICLE; CASE REPORT; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DRUG MEGADOSE; FEMALE; HEMANGIOMATOSIS; HUMAN; INFANT; LASER SURGERY; NEWBORN DISEASE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; CENTRAL NERVOUS SYSTEM VENOUS ANGIOMA; DRUG THERAPY, COMBINATION; FATAL OUTCOME; FEMALE; HEAD AND NECK NEOPLASMS; HEMANGIOMA; HUMANS; INFANT, NEWBORN; INTERFERON ALFA-2A; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; NEOPLASMS, MULTIPLE PRIMARY; SKIN NEOPLASMS;

EID: 0034078311     PISSN: 10344810     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1754.2000.00491.x     Document Type: Article

References (20)

1. 1 Rothe MJ, Rowse D, Grant-Kels JM. Benign hemangiomatosis with aggressive growth of cutaneous lesions. Pediatr. Dermatol. 1991; 8: 140-6.
2. 2 Esterly NB. Cutaneous hemangiomas, vascular stains and malformations, and associated syndromes. Curr. Prob. Dermatol. 1995; 7: 65-108.
3. 3 Stenninger E, Schollin J. Diffuse neonatal hemangiomatosis in a newborn child. Acta Paediatr. 1993; 82: 102-4.
4. 4 Enjolras O, Mulliken JB. Vascular tumors and vascular malformations (new issues). Adv. Dermatol. 1998; 13: 375-422.
5. 5 Enjolras O, Riche MC, Merland JJ, Escande JP. Management of alarming hemangiomas in infancy: A review of 25 cases. Pediatrics 1990; 85: 491-8.
6. 6 Spiller JC, Sharma V, Woods GM, Hall JC, Seidel FG. Diffuse neonatal hemangiomatosis treated successfully with interferon-alpha-2a. J. Am. Acad. Dermatol. 1992; 27: 102-4.
7. 7 Stratte EG, Tope WD, Johnson CL, Swanson NA. Multimodal management of diffuse neonatal hemangiomatosis. J. Am. Acad. Dermatol. 1996; 34 (Part 2): 337-42.
8. 8 Geller JD, Topper SF, Hashimoto K. Diffuse neonatal hemangiomatosis: A new constellation of findings. J. Am. Acad. Dermatol. 1991; 24: 816-18.
9. 9 White CW. Treatment of hemangiomatosis with recombinant interferon alfa. Semin. Hematol. 1990; 27 (Suppl. 4): 15-22.
10. 10 Mulliken JB, Boon LM, Takahashi K, Ohlms LA, Folkman J, Ezekowitz RAB. Pharmacologic therapy for endangering hemangiomas. Curr. Opin. Dermatol. 1995; 6: 109-13.
11. 11 Holden KR, Alexander F. Diffuse neonatal hemangiomatosis. Pediatrics 1970; 46: 411-21.
12. 12 Wu JM, Lin C-S, Wang JN, Luo C-Y, Yu C-Y, Yang H-B. Pulmonary cavernous hemangiomatosis treated with interferon-alpha-2a. Pediatr. Cardiol. 1996; 17: 332-4.
13. 13 Nako Y, Fukushima N, Igarashi T et al. Successful interferon therapy in a neonate with life-threatening Kasabach-Merritt syndrome. J. Perinatol. 1997; 17: 244-7.
14. 14 Folkman J. Clinical applications of research on angiogenesis. N. Engl. J. Med. 1995; 333: 1757-63.
15. 15 Barlow CF, Priebe CJ, Mulliken JB et al. Spastic diplegia as a complication of interferon-alpha-2a treatment of hemangiomas of infancy. J. Pediatr. 1998; 132: 527-30.
16. 16 Payaroles JP, Masferrer JP, Bellvert CG. Treatment of life-threatening infantile hemangiomas with vincristine. N. Engl. J. Med. 1995; 333: 69.
17. 17 Hurvitz CH, Alkalay AL, Sloninsky L, Kallus M, Pomerance JJ. Cyclophosphamide therapy in life-threatening vascular tumors. J. Pediatr. 1986; 109: 360-3.
18. 18 Healy G, McGill T, Friedman EM. Carbon Dioxide laser in subglottic hemangioma. An update. Ann. Otol. Rhinol. Laryngol. 1984; 93 (Part 1): 370-3.
19. 19 Cotton RT, Tewfik TL. Laryngeal stenosis following carbon dioxide laser in subglottic hemangioma. Ann. Otol. Rhinol. Laryngol. 1985; 94 (Part 1): 494-7.
20. 20 Arbiser JL. Signal transduction and regulation of angiogenesis. J. Am. Acad. Dermatol. 1997; 37 (Part 1): 772-3.